TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses

Immunity

Volumn 11, Issue 3, 1999, Pages 379-389

  Nguyen, Linh T ^a   Duncan, Gordon S ^b   Mirtsos, Christine ^b   Ng, Michelle ^b   Speiser, Daniel E ^c   Shahinian, Arda ^b   Marino, Michael W ^d   Mak, Tak W ^a,b   Ohashi, Pamela S ^a   Yeh, Wen Chen ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b AMGEN INSTITUTE   (Canada)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; IMMUNOREGULATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0033198702     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80113-2     Document Type: Article

References (52)

1. Anderson, D.M., Maraskovsky, E., Billingsley, W.L., Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F., Cosman, D., and Galibert, L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
2. Arch, R.H., Gedrich, R.W., and Thompson, C.B. (1998). Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death. Genes Dev. 12, 2821-2830.
3. Argiles, J.M., Lopez-Soriano, J., Busquets, S., and Lopez-Soriano, F.J. (1997). Journey from cachexia to obesity by TNF. Faseb J. 11, 743-751.
4. Ashkenazi, A., and Dixit, V.M. (1998). Death receptors: Signaling and modulation. Science 281, 1305-1308.
5. Baeuerle, P.A., and Henkel, T. (1994). Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
6. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., and Goeddel, D.V. (1996). TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
7. Carballo, E., Lai, W.S., and Blackshear, P.J. (1998). Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281, 1001-1005.
8. Cheng, G., Cleary, A.M., Ye, Z.S., Hong, D.I., Lederman, S., and Baltimore, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
9. Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388, 300-304.
10. Deveraux, Q.L., Roy, N., Stennicke, H.R., Van Arsdale, T., Zhou, Q., Srinivasula, S.M., Alnemri, E.S., Salvesen, G.S., and Reed, J.C. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17, 2215-2223.
11. -/- mice: Protection despite absence of ROI and susceptibility despite presence of RNI. Immunity 7, 419-432.
12. 15N]-nitrate in biological fluids. Anal. Biochem. 126, 131-138.
13. Grewal, I.S., and Flavell, R.A. (1998). CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16, 111-135.
14. Hotamisligil, G.S., Murray, D.L., Choy, L.N., and Spiegelman, B.M. (1994). Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc. Natl. Acad. Sci. USA 91, 4854-4858.
15. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegelman, B.M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668.
16. Hsu, H., Xiong, J., and Goeddel, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 495-504.
17. Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
18. Hsu, H., Lacey, D.L., Dunstan, C.R., Solovyev, I., Colombero, A., Timms, E., Tan, H.L., Elliott, G., Kelley, M.J., Sarosi, I., et al. (1999). Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96, 3540-3545.
19. Ishida, T., Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., et al. (1996a). Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
20. Ishida, T.K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., and Inoue, J. (1996b). TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
21. Jiang, Y.,Woronicz, J.D., Liu, W., and Goeddel, D.V. (1999). Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283, 543-546.
22. Kong, Y.Y., Yoshida, H., Sarosi, I., Tan, H.L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A.J., Van, G., Itie, A., et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323.
23. Laman, J.D., Claassen, E., and Noelle, R.J. (1996). Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16, 59-108.
24. Lee, S.Y., Reichlin, A., Santana, A., Sokol, K.A., Nussenzweig, M.C., and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703-713.
25. Lee, H.H., Dempsey, P.W., Parks, T.P., Zhu, X., Baltimore, D., and Cheng, G. (1999). Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. Proc. Natl. Acad. Sci. USA 96, 1421-1426.
26. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
27. Lomaga, M.A., Yeh, W.C., Sarosi, I., Duncan, G.S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999). TRAF6-deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes Dev. 13, 1015-1024.
28. Marino, M.W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., et al. (1997). Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 8093-8098.
29. McCaren, L., Holland, J.J., and Syverton, J.T. (1959). The mammalian cell-virus relationship. I. Attachment of poliovirus to cultivated cells of primate and non-primate origin. J. Exp. Med. 109, 475-485.
30. McDermott, M.F., Aksentijevich, I., Galon, J., McDermott, E.M., Ogunkolade, B.W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999). Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133-14 4.
31. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
32. Natoli, G., Costanzo, A., Ianni, A., Templeton, D.J., Woodgett, J.R., Balsano, C., and Levrero, M. (1997). Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275, 200-203.
33. Noelle, R.J. (1996). CD40 and its ligand in host defense. Immunity 4, 415-419.
34. Noelle, R.J., Ledbetter, J.A., and Aruffo, A. (1992). CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13, 431-433.
35. Nussler, A.K., and Billiar, T.R. (1993). Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leuk. Biol. 54, 171-178.
36. Oxenius, A., Campbell, K.A., Maliszewski, C.R., Kishimoto, T., Kikutani, H., Hengartner, H., Zinkernagel, R.M., and Bachmann, M.F. (1996). CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions. J. Exp. Med. 183, 2209-2218.
37. Pan, G., Bauer, J.H., Haridas, V., Wang, S., Liu, D., Yu, G., Vincenz, C., Aggarwal, B.B., Ni, J., and Dixit, V.M. (1998). Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett. 431, 351-356.
38. Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Kronke, M., and Mak, T.W. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
39. Pullen, S.S., Miller, H.G., Everdeen, D.S., Dang, T.T.A., Crute, J.J., and Kehry, M.R. (1998). CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836-11845.
40. Regnier, C.H., Tomasetto, C., Moog-Lutz, C., Chenard, M.P., Wendling, C., Basset, P., and Rio, M.C. (1995). Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715-25721.
41. Roost, H.P., Charan, S., and Zinkernagel, R.M. (1990). Analysis of the kinetics of antiviral memory T help in vivo: Characterization of short lived cross-reactive T help. Eur. J. Immunol. 20, 2547-2554.
42. Rothe, M., Wong, S.C., Henzel, W.J., and Goeddel, D.V. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
43. Rothe, M., Sarma, V., Dixit, V.M., and Goeddel, D.V. (1995). TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269, 1424-1427.
44. Roy, N., Deveraux, Q.L., Takahashi, R., Salvesen, G.S., and Reed, J.C. (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 6914-6925.
45. Ruddle, N.H. (1992). Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr. Opin. Immunol. 4, 327-332.
46. Sato, T., Irie, S., and Reed, J.C. (1995). A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358, 113-118.
47. Scott, D.W., and Gershon, R.K. (1970). Determination of total and mercaptoethanol-resistant antibody in the same serum sample. Clin. Exp. Immunol. 6, 313-316.
48. Takeuchi, M., Rothe, M., and Goeddel, D.V. (1996). Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 271, 19935-19942.
49. Tewari, M., and Dixit, V.M. (1996). Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet Dev. 6, 39-44.
50. Tsukamoto, N., Kobayashi, N., Azuma, S., Yamamoto, T., and Inoue, J. (1999). Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 96, 1234-1239.
51. Yeh, W.C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J.L., Ferrick, D., Hum, B., Iscove, N., et al. (1997). Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
52. Zinkernagel, R.M., Cooper, S., Chambers, J., Lazzarini, R.A., Hengartner, H., and Arnheiter, H. (1990). Virus-induced autoantibody response to a transgenic viral antigen. Nature 345, 68-71.